MDLN
Medline Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$32.16
−0.65%Oct 19, 2026, 10:07 UTC
Bleichmar Fonti & Auld LLP announced an investigation into Medline Inc. over potential securities fraud.
Source:Oct 15, 2026, 20:25 UTC
Joseph P. Baratta resigned from Medline Inc.'s Board of Directors, effective December 31, 2026.
Oct 15, 2026, 18:17 UTC
Medline Inc. announced plans to build a new 800,000-square-foot distribution center in Van Buren Township, Michigan.
Source:Oct 15, 2026, 13:45 UTC
The FDA classified Medline Inc.’s removal of convenience kits containing affected BD ChloraPrep applicators as a Class I recall and instructed customers to quarantine and destroy the entire kit.
Source:Oct 6, 2026, 13:00 UTC
Medline Inc. announced it will report its third quarter 2026 financial results on November 4, 2026, with a press release before market open and a webcast and conference call at 9:30am ET.
Source:Aug 25, 2026, 23:59 UTC
The U.S. Food and Drug Administration posted multiple recall alerts in August 2026 for medical kits containing recalled sodium chloride ampules manufactured by Huons Co., Ltd., affecting kits from Becton Dickinson, Medline, AVID Medical, and Medical Action Industries.
Source:Aug 5, 2026, 11:30 UTC
Medline reported second quarter 2026 net sales of $7.7 billion, up 11.6%, and net income of $139 million, down 58.3%, for the three months ended June 27, 2026.
Jul 20, 2026, 17:44 UTC
Medline announced plans to open a new 1 million-square-foot distribution center in Perris, California.
Source:Jul 9, 2026, 00:00 UTC
Stephen L. Miller retired as Chief Operating Officer of Medline Inc., effective August 30, 2026.
Jul 8, 2026, 00:54 UTC
Hagens Berman Sobol Shapiro launched an investigation into Medline Inc. regarding potential securities law violations.
Source:Jun 23, 2026, 11:04 UTC
Access Vascular and Medline entered a multi-year agreement to launch cobranded next-generation vascular access catheters.
Source:Jun 8, 2026, 08:00 UTC
Medline International B.V. expanded its manufacturing center in Partizánske, Slovakia, to support long-term growth in Europe.
Jun 3, 2026, 00:00 UTC
The U.S. FDA issued a warning letter to Medline over violations of manufacturing quality standards, the second such action against the company in two months.
Source:Jun 2, 2026, 00:00 UTC
Medline Inc. issued $1.25 billion 5.000% senior secured notes due 2031 and $750 million 5.250% senior secured notes due 2033, and amended its credit agreement to establish a $2.75 billion senior secured 2033 Refinancing Term Loan Facility to replace the existing 2030 Term Loan Facility.